Quantum Biopharma Ltd. SEC filings QNTM
Quantum Biopharma Ltd. has 357 filings in SEC EDGAR's recent list, going back to Oct 15, 2019. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Dec 22, 2025 | — |
| 424B5 | Prospectus supplement | Oct 31, 2025 | — |
| 424B5 | Prospectus supplement | Aug 27, 2024 | — |
| 424B5 | Prospectus supplement | Feb 20, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 26, 2023 | — |
| F-X | Form f-x | Apr 2, 2021 | — |
| F-10 | Form f-10 | Apr 2, 2021 | — |
| FWP | Free writing prospectus | Jul 31, 2020 | — |
| F-10/A | Form f-10/a | Jun 17, 2020 | — |
| F-X | Form f-x | Feb 28, 2020 | — |
| F-10 | Form f-10 | Feb 28, 2020 | — |
| F-X | Form f-x | Dec 6, 2019 | — |
Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QNTM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ontario, Canada
- Headquarters
- Toronto
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1771885
- Former names
- FSD Pharma Inc. (until Aug 15, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.